XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.19.2

10. Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2019
Segment Reporting [Abstract] |
10. Segment Information | Aemetis recognizes two reportable geographic segments: “North America” and “India.” The “North America” operating segment includes the Keyes Plant in Keyes, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near the Keyes Plant, the Goodland Plant in Kansas, and the research and development facility in Minnesota. The “India” operating segment includes the Company’s 50 million gallon per year nameplate capacity biodiesel manufacturing plant (“Kakinada Plant”), the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly. Summarized financial information by reportable segment for the three and six months ended June 30, 2019 and 2018 follows:
|  | Three months ended June 30, 2019 |  |  | Three months ended June 30, 2018 |
|  | North America |  |  | India |  |  | Total Consolidated |  |  | North America |  |  | India |  |  | Total Consolidated |
Revenues |  | $ | 39,486 |  |  | $ | 11,133 |  |  | $ | 50,619 |  |  | $ | 39,628 |  |  | $ | 5,400 |  |  | $ | 45,028 |
Cost of goods sold |  |  | 38,483 |  |  |  | 8,863 |  |  |  | 47,346 |  |  |  | 37,079 |  |  |  | 5,181 |  |  |  | 42,260 |
Gross profit |  |  | 1,003 |  |  |  | 2,270 |  |  |  | 3,273 |  |  |  | 2,549 |  |  |  | 219 |  |  |  | 2,768 |
Other Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  | 90 |  |  |  | - |  |  |  | 90 |  |  |  | 55 |  |  |  | - |  |  |  | 55 |
Selling, general and administrative expenses |  |  | 3,190 |  |  |  | 755 |  |  |  | 3,945 |  |  |  | 3,420 |  |  |  | 169 |  |  |  | 3,589 |
Interest expense |  |  | 6,470 |  |  |  | 116 |  |  |  | 6,586 |  |  |  | 5,199 |  |  |  | 152 |  |  |  | 5,351 |
Accretion of Series A preferred units |  |  | 471 |  |  |  | - |  |  |  | 471 |  |  |  | - |  |  |  | - |  |  |  | - |
Loss contingency on litigation |  |  | 6,200 |  |  |  | - |  |  |  | 6,200 |  |  |  | - |  |  |  | - |  |  |  | - |
Other income |  |  | (74 | ) |  |  | (15 | ) |  |  | (89 | ) |  |  | (2 | ) |  |  | (3 | ) |  |  | (5 | )
Income (loss) before income taxes |  | $ | (15,344 | ) |  | $ | 1,414 |  |  | $ | (13,930 | ) |  | $ | (6,123 | ) |  | $ | (99 | ) |  | $ | (6,222 | )
Capital expenditures |  | $ | 234 |  |  | $ | 206 |  |  | $ | 440 |  |  | $ | 567 |  |  | $ | 208 |  |  | $ | 775 |
Depreciation |  |  | 947 |  |  |  | 149 |  |  |  | 1,096 |  |  |  | 992 |  |  |  | 157 |  |  |  | 1,149 |
|  | For the six months ended June 30, 2019 |  |  | For the six months ended June 30, 2018 |
|  | North America |  |  | India |  |  | Total Consolidated |  |  | North America |  |  | India |  |  | Total Consolidated |
Revenues |  | $ | 76,122 |  |  | $ | 16,385 |  |  | $ | 92,507 |  |  | $ | 76,804 |  |  | $ | 11,242 |  |  | $ | 88,046 |
Cost of goods sold |  |  | 75,450 |  |  |  | 14,135 |  |  |  | 89,585 |  |  |  | 73,061 |  |  |  | 10,351 |  |  |  | 83,412 |
Gross profit |  |  | 672 |  |  |  | 2,250 |  |  |  | 2,922 |  |  |  | 3,743 |  |  |  | 891 |  |  |  | 4,634 |
Other Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  | 123 |  |  |  | - |  |  |  | 123 |  |  |  | 117 |  |  |  | - |  |  |  | 117 |
Selling, general and administrative expenses |  |  | 7,256 |  |  |  | 930 |  |  |  | 8,186 |  |  |  | 6,935 |  |  |  | 461 |  |  |  | 7,396 |
Interest expense |  |  | 12,512 |  |  |  | 283 |  |  |  | 12,795 |  |  |  | 14,083 |  |  |  | 296 |  |  |  | 14,379 |
Accretion of Series A preferred units |  |  | 920 |  |  |  | - |  |  |  | 920 |  |  |  | - |  |  |  | - |  |  |  | - |
Loss contingency on litigation |  |  | 6,200 |  |  |  | - |  |  |  | 6,200 |  |  |  | - |  |  |  | - |  |  |  | - |
Other expense (income) |  |  | 37 |  |  |  | (749 | ) |  |  | (712 | ) |  |  | 43 |  |  |  | 20 |  |  |  | 63 |
Income (loss) before income taxes |  | $ | (26,376 | ) |  |  | 1,786 |  |  |  | (24,590 | ) |  | $ | (17,435 | ) |  |  | 114 |  |  |  | (17,321 | )
Capital expenditures |  | $ | 585 |  |  | $ | 453 |  |  | $ | 1,038 |  |  | $ | 1,057 |  |  | $ | 714 |  |  | $ | 1,771 |
Depreciation |  |  | 1,941 |  |  |  | 293 |  |  |  | 2,234 |  |  |  | 1,984 |  |  |  | 315 |  |  |  | 2,299 |
North America: During the three and six months ended June 30, 2019, the Company’s revenues from ethanol, WDG, and corn oil were made pursuant to the Corn Procurement and Working Capital Agreement established between the Company and J.D. Heiskell. Sales of ethanol, WDG, and corn oil to J.D. Heiskell accounted for 99.8% and 99.9% of the Company’s North America segment revenues for the three and six months ended June 30, 2019, respectively. During the three and six months ended June 30, 2018, the Company’s revenues from ethanol, WDG, and corn oil were made pursuant to the Corn Procurement and Working Capital Agreement established between the Company and J.D. Heiskell. Sales of ethanol, WDG, and corn oil to J.D. Heiskell accounted for 99.7% of the Company’s North America segment revenues for both the three and six months ended June 30, 2018. India. During the three months ended June 30, 2019, three biodiesel customers accounted for 29%, 24% and 20% of the Company’s consolidated India segment revenues while none of the refined glycerin customers accounted for more than 10%, compared to two biodiesel customers accounting for 46% and 10% of the Company’s consolidated India segment revenues and one refined glycerin customer accounting for 11% of such revenues during the three months ended June 30, 2018. During the six months ended June 30, 2019, three biodiesel customers accounted for 35%, 16% and 13% of the Company’s consolidated India segment revenues while none of the refined glycerin customers accounted for more than 10% of such revenues, compared to two biodiesel customers accounting for 54% and 11% of the Company’s consolidated India segment revenues and none of the refined glycerin customers accounting for more than 10% of such revenues during the six months ended June 30, 2018. Total assets by segment consist of the following:
|  | As of |
|  | June 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
North America |  | $ | 77,408 |  |  | $ | 78,149 |
India |  |  | 14,927 |  |  |  | 13,672 |
Total Assets |  | $ | 92,335 |  |  | $ | 91,821 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration